Related Experiment Video
Updated: Dec 12, 2025

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
Interstage Home Monitoring for Infants With Single Ventricle Heart Disease: Education and Management: A Scientific
Insights
Home monitoring for infants with single ventricle heart disease significantly improves outcomes. This approach helps detect critical changes early, reducing mortality during the interstage period between surgeries.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Surgical Palliation
Background:
- The interstage period for infants with single ventricle heart disease (SVHD) historically had high mortality rates.
- In-home surveillance strategies were developed to monitor infants post-initial palliation and pre-second stage palliation.
- These strategies aim to detect physiologic changes preceding hemodynamic decompensation.
Purpose of the Study:
- To summarize current knowledge on interstage home monitoring for infants with SVHD.
- To review key components of successful home monitoring programs.
- To discuss outcomes, quality improvement, and future research directions.
Main Methods:
- Review of existing literature and national quality improvement initiatives.
- Synthesis of data on readiness for discharge, caregiver support, and surveillance practices.
- Analysis of interstage outcomes associated with home monitoring.
Main Results:
- Interstage home monitoring adoption is linked to significantly improved morbidity and mortality.
- Effective monitoring requires robust caregiver education, healthcare team coordination, and standardized surveillance.
- National quality improvement efforts have contributed to better interstage outcomes.
Conclusions:
- Interstage home monitoring is a critical component in managing infants with SVHD.
- Comprehensive programs enhance patient safety and reduce adverse events.
- Further research is needed to optimize monitoring protocols and long-term outcomes.
Abstract:
This scientific statement summarizes the current state of knowledge related to interstage home monitoring for infants with shunt-dependent single ventricle heart disease. Historically, the interstage period has been defined as the time of discharge from the initial palliative procedure to the time of second stage palliation. High mortality rates during the interstage period led to the implementation of in-home surveillance strategies to detect physiologic changes that may precede hemodynamic decompensation in interstage infants with single ventricle heart disease. Adoption of interstage home monitoring practices has been associated with significantly improved morbidity and mortality. This statement will review in-hospital readiness for discharge, caregiver support and education, healthcare teams and resources, surveillance strategies and practices, national quality improvement efforts, interstage outcomes, and future areas for research. The statement is directed toward pediatric cardiologists, primary care providers, subspecialists, advanced practice providers, nurses, and those caring for infants undergoing staged surgical palliation for single ventricle heart disease.
More Related Videos
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
13:44Author Spotlight: Importance of Single Cell Sorting in Isolating Purified Populations of Mesenchymal Stem Cells
Published on: November 10, 2023